Image

Biomarkers Related to PSCI: An fNIRS Study

Biomarkers Related to PSCI: An fNIRS Study

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

This is an fNIRS study performed to identify biomarkers related to post-stroke cognitive impairment.

Description

This was an initial screening and preliminary intervention study. Both healthy subject and stroke patients will be included in this study. Brain functional activation of each subject during the cognitive task (Stroop task, 1-back task and verbal fluency test) will be evaluated using functional near-infrared spectroscopy (fNIRS). Cognitive function related scale assessment included Mental State Examination Scale (MMSE), Montreal Cognitive Assessment (MoCA), drawing clock test (DCT), Shape trials test A.B (STT-A, STT-B), standardized digital modal test (SDMT), auditory verbal learning test-Huashan version (AVLT-H), and activity of daily living (ADL) scale will be used to evaluate the function of each patient. Biomarkers related to post-stroke cognitive impairment will be identified by by comparing differences in brain activation and brain network connectivity between patients and healthy subjects.

Eligibility

Inclusion Criteria:

Stroke patients:

  1. Diagnosis of stroke confirmed by neuroimaging (CT or MRI)
  2. 18-80 years old
  3. Able to complete the cognitive task
  4. Able to follow instructions to complete the trial
  5. Patients who signed an informed consent form.

Healthy Subjects:

  1. No abnormalities on cranial
  2. 18-80 years old
  3. Able to complete cognitive task
  4. Able to follow instructions to complete the trial
  5. not taking medications.
  6. Subjects who signed an informed consent form.

Exclusion Criteria:

Stroke patients:

  1. Inability to tolerate the test due to organic diseases
  2. Serious mental illness that prevents them from cooperating with or tolerating the trial
  3. Pregnant or lactating women
  4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction.

Healthy Subjects:

  1. Inability to tolerate the test due to organic diseases
  2. Serious mental illness that prevents them from cooperating with or tolerating the trial.
  3. Pregnant or lactating women
  4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction

Study details
    Stroke
    Cognitive Decline

NCT06703307

Dingqun Bai

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.